Researchers Develop A Method To Evaluate Variations Identified In Breast Cancer...Medical News Today: 1 views since Tuesday, July 8, 2008 at 07:05 PMUsing mouse embryonic stem cells, researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have developed a new method to evaluate which mutations, or changes, in a gene known to increase breast cancer susceptibility, may lead to cancer. The new test, called a functional assay, is more comprehensive and reliable than most current methods.
Published in: Institutes